Evolent Health
174 hedge funds and large institutions have $585M invested in Evolent Health in 2019 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 80 increasing their positions, 45 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
174
Holders Change
-9
Holders Change %
-4.92%
% of All Funds
3.82%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
20
Increased
80
Reduced
45
Closed
27
Calls
$12.1M
Puts
$2.63M
Net Calls
+$9.49M
Net Calls Change
+$5.29M
Top Buyers
| 1 |
SAM
Silvercrest Asset Management
New York
|
+$14.7M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$11.6M |
| 3 |
JPMorgan Chase & Co
New York
|
+$10.7M |
| 4 |
BlackRock
New York
|
+$10.1M |
| 5 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
+$8.4M |
Top Sellers
| 1 |
Marshall Wace
London,
United Kingdom
|
-$8.58M |
| 2 |
Citigroup
New York
|
-$8.11M |
| 3 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$8.03M |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
-$5.82M |
| 5 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$5.07M |
